Form 4 for GILD Gilead Sciences
Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-06 · accession 0001127602-23-003825 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-07 | 2023-02-06 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +1,864 | 32.6K | +6% | — |
| D | 2023-02-07 | 2023-02-06 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $86.36 | -565 | 32.0K | -2% | -$48.8K |
| D | 2023-02-07 | 2023-02-06 | GILD | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | -1,864 | 11.1K | -14% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | M | A | 1,864 | — | 32,575 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2023-02-06 | F | D | 565 | $86.36 | 32,010 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-02-06 | M | D | 1,864 | — | 11,060 | D | — · — to — | 1,864 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested. |